FDA Inspection 1200534 — Little Company of Mary

Little Company of Mary — FEI 3008563037

The FDA completed an inspection of Little Company of Mary on March 2, 2023 in Jasper, IN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 2, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Jasper, IN (United States)